Tricol Biomedical Inc - Product Pipeline Analysis, 2023 Update

Summary


Tricol Biomedical Inc (Tricol Biomedical), a subsidiary of Tricol International Group Ltd, is a medical device company that develops, manufactures and markets hemostasis and infection control products. The company’s products include chitogauze pro and guardacare pro, hemcon guardiva, hemcon patch pro, guardacarexr surgical and hemcon bandages pro. It offers products under the brands OneStop, HemCon and m.doc. Tricol Biomedical offers its products for use in the treatment of trauma and surgery and dressing products, military medics, paramedics, first responders and consumers. The company supplies its products through distributors in Europe, Asia-Pacific and the Middle East. Tricol Biomedical is headquartered in Portland, Oregon, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Tricol Biomedical Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


Tricol Biomedical Inc Company Overview
Tricol Biomedical Inc Company Snapshot
Tricol Biomedical Inc Pipeline Products and Ongoing Clinical Trials Overview
Tricol Biomedical Inc – Pipeline Analysis Overview
Tricol Biomedical Inc - Key Facts
Tricol Biomedical Inc - Major Products and Services
Tricol Biomedical Inc Pipeline Products by Development Stage
Tricol Biomedical Inc Pipeline Products Overview
CGHD+DW Device
CGHD+DW Device Product Overview
Chitosan Endoluminal Hemostatic Dressing Catheter Device
Chitosan Endoluminal Hemostatic Dressing Catheter Device Product Overview
Hemostatic Urinary Catheter Device (HUCD)
Hemostatic Urinary Catheter Device (HUCD) Product Overview
Plasfusion Lyophilized Plasma System
Plasfusion Lyophilized Plasma System Product Overview
Tricol Biomedical Inc - Key Competitors
Tricol Biomedical Inc - Key Employees
Tricol Biomedical Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Tricol Biomedical Inc, Recent Developments
May 05, 2021: Tricol Biomedical launches sales and marketing agency agreement with NorthStar Sales Alliance
Jan 06, 2021: Medline Expanding Clinician Access to Products Designed to Safely Control Bleeding
May 06, 2015: Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device
Apr 07, 2015: HemCon Medical Technologies Launches into Chinese Market
Mar 24, 2015: HemCon Medical Technologies Receives 2015 Best of Portland Award
Feb 17, 2015: HemCon Medical Technologies Continues Transition to Innovation Leader
Nov 03, 2014: HemCon Medical Technologies Awarded Hemostasis and Compression Products Agreement With Premier
Sep 16, 2014: HemCon Medical Technologies Projects Strong Third Quarter Revenues
Sep 03, 2014: HemCon Medical Technologies Announces Strategic Facility Relocation to Support Rapid Growth and New Product Development
Jun 12, 2014: HemCon Medical Technologies Announces New Research on ChitoGauze® Published in Leading European Trauma Journal
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Tricol Biomedical Inc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Tricol Biomedical Inc Pipeline Products by Equipment Type
Table 3: Tricol Biomedical Inc Pipeline Products by Indication
Table 4: Tricol Biomedical Inc, Key Facts
Table 5: Tricol Biomedical Inc, Major Products and Services
Table 6: Tricol Biomedical Inc Number of Pipeline Products by Development Stage
Table 7: Tricol Biomedical Inc Pipeline Products Summary by Development Stage
Table 8: CGHD+DW Device - Product Status
Table 9: CGHD+DW Device - Product Description
Table 10: Chitosan Endoluminal Hemostatic Dressing Catheter Device - Product Status
Table 11: Chitosan Endoluminal Hemostatic Dressing Catheter Device - Product Description
Table 12: Hemostatic Urinary Catheter Device (HUCD) - Product Status
Table 13: Hemostatic Urinary Catheter Device (HUCD) - Product Description
Table 14: Plasfusion Lyophilized Plasma System - Product Status
Table 15: Plasfusion Lyophilized Plasma System - Product Description
Table 16: Tricol Biomedical Inc, Key Employees
Table 17: Tricol Biomedical Inc, Subsidiaries
Table 18: Glossary
List of Figures
Figure 1: Tricol Biomedical Inc Pipeline Products by Equipment Type
Figure 2: Tricol Biomedical Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings